DUBLIN, Mar. 21, 2017 /PRNewswire/ --
Dublin - Research and Markets has announced the addition of the "Global Anticoagulant Market 2017-2021" report to their offering.
The global anticoagulant market to grow at a CAGR of 7.42% during the period 2017-2021.
The report, Global Anticoagulant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
One trend in the market is the strategic alliance. Mergers and acquisitions (M&A) lead the industry toward further consolidation, which, in turn, improves the penetration of the related products. Considering such alliances lead to broader geographical footprint and wider customer base, the underlying market witnesses the benefits regarding volume growth.
According to the report, one driver in the market is the increasing demand for NOACs. The increasing adoption rates of NOACs is driving the market growth. NOACs target either thrombin or factor Xa to prevent and treat thrombosis. They show quick action and do not require continuous monitoring. They also have better safety and efficacy profiles when compared with conventional therapies such as warfarin. Hence, the adoption rate of NOACs has seen an increment in the anticoagulation market. It was observed that 62% of all the anticoagulant prescriptions were for novel oral anticoagulant during 2010-2013.
Key vendors
- Bayer HealthCare
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
- Johnson & Johnson
- Sanofi
Other prominent vendors
- Abbott Vascular
- Abiomed
- AtriCure
- Biosensors International
- Biotronik
- BioVentrix
- C. R. Bard
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation by ROA
PART 09: Market segmentation by drug class
PART 10: Market segmentation by application
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Key vendor analysis
PART 19: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/2pqvsz/global
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article